CANLI
Yükleniyor Veriler getiriliyor…
SCI-Expanded Özgün Makale Scopus
The use of adjunctive topical mitomycin in endoscopic congenital choanal atresia repair
International Journal of Pediatric Otorhinolaryngology 2010 Cilt 74 Sayı 7
Scopus Eşleşmesi Bulundu
21
Atıf
74
Cilt
733-736
Sayfa
Scopus Yazarları: Mete Kaan Bozkurt, B. Keles, A. Azimov, Kayhan Öztürk, Hamdi Arbaǧ
Özet
Objective: To evaluate the efficacy of topical mitomycin in providing the patency of the neochoanae in children undergoing transnasal endoscopic congenital choanal atresia (CA) repair. Methods: A retrospective analysis of surgical results in CA patients who were treated in Selcuk University, Meram Medical Faculty, Department of Otolaryngology between November 2002 and November 2009 was performed. All patients underwent transnasal endoscopic approach using nasal telescopes and traditional sinus instrumentation together with a microdebrider. Mitomycin was used according to the senior surgeon's preference, and certainly not in a randomized fashion. After completion of surgery, mitomycin 0.4. mg/ml was applied to the neochoanae for 3. min. Postoperative stenting was performed in all patients. Results: CA was unilateral in 8 subjects (mean age 71.8. ±. 41.7 months; range 18 months-144 months) and bilateral in 12 subjects (mean age 4.6. ±. 1.3 days; range 3-7 days). Among the subjects, 75% was female in both groups. Fourteen subjects under endoscopic repair without mitomycin, whereas mitomycin was used in 6 patients (4 bilateral, 2 unilateral). Stents were left at least 3 weeks postoperatively (mean 31. ±. 10 days; range 21-45 days). The patients were followed-up at least 6 months (range 6-72 months). No symptomatic restenosis requiring further dilatations was seen in patients treated with preoperative mitomycin, whereas restenosis was detected in 6 subjects (42.9%) treated without mitomycin postoperatively within 6 months period (Fisher's Exact Test 2-sided, p=. 0.12). These subjects underwent revision endoscopic repair with mitomycin and had no need for further dilatations with acceptable control of symptoms during a follow-up period ranging between 14 and 78 months. Conclusion: Mitomycin improves the surgical treatment outcome of CA and reduces the rate of restenosis significantly without any complications. However, further prospective randomized studies are needed to fully investigate the benefits of mitomycin therapy in CA surgery. © 2010 Elsevier Ireland Ltd.
Anahtar Kelimeler (Scopus)
Choanal atresia Endoscopic Mitomycin c
Scimago Dergi Bilgisi Otomatik ISSN Eşleştirmesi 2010 yılı verileri
International Journal of Pediatric Otorhinolaryngology
Q1
SJR Quartile
0,798
SJR Skoru
96
H-Index
Kategoriler: Medicine (miscellaneous) (Q1) · Otorhinolaryngology (Q1) · Pediatrics, Perinatology and Child Health (Q1)
Alanlar: Medicine
Ülke: Ireland · Elsevier Ireland Ltd
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir. Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.

Anahtar Kelimeler

Choanal atresia Endoscopic Mitomycin c

Makale Bilgileri

Dergi International Journal of Pediatric Otorhinolaryngology
ISSN 01655876
Yıl 2010 / 7. ay
Cilt / Sayı 74 / 7
Sayfalar 733 – 736
Makale Türü Özgün Makale
Hakemlik Hakemli
Endeks SCI-Expanded
Yayın Dili İngilizce
Kapsam Uluslararası
Toplam Yazar 5 kişi
Erişim Türü Elektronik
Erişim Linki Makaleye Git
Alan Sağlık Bilimleri Temel Alanı- Kulak Burun Boğaz Hastalıkları

YÖKSİS Yazar Kaydı

Yazar Adı BOZKURT METE KAAN,ÇOLPAN BAHAR,AZIMOV AHMET,ÖZTÜRK KAYHAN,ARBAĞ HAMDİ
YÖKSİS ID 2093926